Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations

At the time of writing, more than 440 million confirmed coronavirus disease 2019 (COVID-19) cases and more than 5.97 million COVID-19 deaths worldwide have been reported by the World Health Organization since the start of the outbreak of the pandemic in Wuhan, China. During the COVID-19 pandemic, ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ming-Shao Tsai, Wei-Tai Shih, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen, Ching-Yuan Wu
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2022-05-01
Colecção:Biomedicine & Pharmacotherapy
Assuntos:
SARS-CoV-2
Spike protein
GB-1
Glycyrrhizic acid
COVID-19
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S0753332222001901
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados